Product Description

In clinic, HD+HP treatment by association of hemodialysis (HD) & hemoperfusion(HP) could clear various uremic toxins in ESRD patients, decrease morbidity of complications in long-term and short-term, prolong life span and improve life quality. The product is hereinafter named as hemoperfusion cartridge for short.

[Product Application]

1.     Product purpose: the product could adsorb uremic toxins such as parathyrin,β2-microglobulin, leptin, oxidation protein products, end-stage glycosylation products, homocysteine, feritin, angiotensin, interleukin 1, 6 etc. in hemodialysis patients.

2.     Application of patients: the product is applicable to hemodialysis patients, and HP+HD joint treatment which could prevent and improve long-term hemodialysis complications such as renal osteopathy, refractory skin pruritus, peripheral neuropathy, cardiovascular disease, refractory hypertension, nephro-encephalopathy, malnutrition etc.